Status:
COMPLETED
HFR A-equilibrium on Cardiovascular Stability
Lead Sponsor:
Azienda Ospedaliera di Lecco
Collaborating Sponsors:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Centre Pasteur Vallery Radot
Conditions:
Hypotension
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
Aim of the present randomized controlled multinational trial is the comparison of a novel biofeedback system on sodium profiling applied to a endogenous hemodiafiltration therapy, with the standard (n...
Detailed Description
Online hemodiafiltration (OL-HDF) has been recently associated with better patient survival in comparison with standard hemodialysis in some large observational studies (Canaud et al, KI, 2006; Vilar ...
Eligibility Criteria
Inclusion
- Patients with more than 30% of dialysis complicated by hypotension
- age between 18 and 85 yers
- time on dialysis greater than 6 months
- residual creatinine clearance less than 2 ml/min/1.73 m2
- native fistula or central venous catheter with blood flow rate greater than 250 ml/min
Exclusion
- Life expectancy less than 1 year
- solid active neoplasm
- pregnancy
- major event in the previous 3 months (ictus, myocardial infarction, cachexia)
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01414842
Start Date
April 1 2007
End Date
December 1 2008
Last Update
August 29 2011
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Erasme
Brussels, Belgium
2
Dept. of Nephrology and Dialysis Centre Pasteur Vallery Radat
Paris, France
3
Civil Hospital Bretagne Atlantique
Vannes, France
4
Clinic of Internal Medicine
Rostock, Germany